NCT05537194View on ClinicalTrials.gov

Effects of Dihydropyridine Calcium Channel Inhibitors on Respiratory Gas Exchanges in the Intensive Care Unit: a Pharmacovigilance Study in VigiBase® and a Comparison With Urapidil

CompletedOBSERVATIONAL

Enrollment

32,000,000

Participants

Timeline

Start Date

January 1, 1963

Primary Completion Date

August 14, 2022

Study Completion Date

August 14, 2022

Conditions

Hypoxia

Interventions

DRUG

dihydropyridine calcium channel inhibitors use

administration of dihydropyridine calcium channel inhibitors

Trial Locations (1)

14033

Caen University Hospital, Department of Pharmacology, Caen

All Listed Sponsors

lead

University Hospital, Caen

OTHER

NCT05537194 - Effects of Dihydropyridine Calcium Channel Inhibitors on Respiratory Gas Exchanges in the Intensive Care Unit: a Pharmacovigilance Study in VigiBase® and a Comparison With Urapidil | Biotech Hunter | Biotech Hunter